Synopsis of Guidelines for the Clinical Management of Cerebral Cavernous Malformations: Consensus Recommendations Based on Systematic Literature Review by the Angioma Alliance Scientific Advisory Board Clinical Experts Panel

Amy Akers, Rustam Al-Shahi Salman, Issam A Awad, Kristen Dahlem, Kelly Flemming, Blaine Hart, Helen Kim, Ignacio Jusue-Torres, Douglas Kondziolka, Cornelia Lee, Leslie Morrison, Daniele Rigamonti, Tania Rebeiz, Elisabeth Tournier-Lasserve, Darrel Waggoner, Kevin Whitehead, Amy Akers, Rustam Al-Shahi Salman, Issam A Awad, Kristen Dahlem, Kelly Flemming, Blaine Hart, Helen Kim, Ignacio Jusue-Torres, Douglas Kondziolka, Cornelia Lee, Leslie Morrison, Daniele Rigamonti, Tania Rebeiz, Elisabeth Tournier-Lasserve, Darrel Waggoner, Kevin Whitehead

Abstract

Background: Despite many publications about cerebral cavernous malformations (CCMs), controversy remains regarding diagnostic and management strategies.

Objective: To develop guidelines for CCM management.

Methods: The Angioma Alliance ( www.angioma.org ), the patient support group in the United States advocating on behalf of patients and research in CCM, convened a multidisciplinary writing group comprising expert CCM clinicians to help summarize the existing literature related to the clinical care of CCM, focusing on 5 topics: (1) epidemiology and natural history, (2) genetic testing and counseling, (3) diagnostic criteria and radiology standards, (4) neurosurgical considerations, and (5) neurological considerations. The group reviewed literature, rated evidence, developed recommendations, and established consensus, controversies, and knowledge gaps according to a prespecified protocol.

Results: Of 1270 publications published between January 1, 1983 and September 31, 2014, we selected 98 based on methodological criteria, and identified 38 additional recent or relevant publications. Topic authors used these publications to summarize current knowledge and arrive at 23 consensus management recommendations, which we rated by class (size of effect) and level (estimate of certainty) according to the American Heart Association/American Stroke Association criteria. No recommendation was level A (because of the absence of randomized controlled trials), 11 (48%) were level B, and 12 (52%) were level C. Recommendations were class I in 8 (35%), class II in 10 (43%), and class III in 5 (22%).

Conclusion: Current evidence supports recommendations for the management of CCM, but their generally low levels and classes mandate further research to better inform clinical practice and update these recommendations. The complete recommendations document, including the criteria for selecting reference citations, a more detailed justification of the respective recommendations, and a summary of controversies and knowledge gaps, was similarly peer reviewed and is available on line www.angioma.org/CCMGuidelines .

Keywords: Angioma; Cavernous; Guidelines; Malformation; Recommendations.

© 2017 Angioma Alliance.

Figures

FIGURE.
FIGURE.
Annual ICH per patient-year by combined, first, or recurrent ICH. Studies are ordered by selection criteria and date. ICH rates and 95% CI (when available) from published papers are plotted. Figure adapted and updated from Al-Shahi Salman et al, available at http://www.sciencedirect.com/science/article/pii/S1474442212700042, and licensed under the Creative Commons Attribution License (CC BY).

References

    1. Samarasekera N, Poorthuis M, Kontoh K et al. . Guidelines for the Management of Cerebral Cavernous Malformations in Adults, 2005. Available at: Accessed January 2015.
    1. Tonelli MR. In defense of expert opinion. Acad Med. 1999;74(11):1187–1192.
    1. Awad I, Barrow DL. Cavernous Malformations. United States: American Association of Neurological Surgeons; 1993.
    1. Rigamonti D. Cavernous Malformations of the Nervous System. Cambridge, England: Cambridge University Press; 2011.
    1. Lanzino G. Cavernous Malformations of the Brain and Spinal Cord. New York, NY: Thieme; 2011.
    1. Battistini S, Catapano D, Cerase A et al. . Angiomi cavernosi (o Cavernomi) cerebrali consensus diagnostico-terapeutico. CCM Italia. 2009. Available at: Accessed January 2015.
    1. Hemphill JC 3rd, Greenberg SM, Anderson CS et al. . Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2015;46(7):2032–2060.
    1. Hsu C, Stanford B. The Delphi technique: making sense of consensus. Pract Assess Res Eval. 2007;12:(10)1–8.
    1. Morris Z, Whiteley WN, Longstreth WT Jr et al. . Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ. 2009;339:b3016.
    1. Otten P, Pizzolato GP, Rilliet B, Berney J. 131 cases of cavernous angioma (cavernomas) of the CNS, discovered by retrospective analysis of 24,535 autopsies. Neurochirurgie. 1989;35(2):82–83, 128-131.
    1. Al-Holou WN, O’Lynnger TM, Pandey AS et al. . Natural history and imaging prevalence of cavernous malformations in children and young adults. J Neurosurg Pediatr. 2012;9(2):198–205.
    1. Al-Shahi R, Bhattacharya JJ, Currie DG et al. . Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke. 2003;34(5):1163–1169.
    1. Al-Shahi Salman R, Hall JM, Horne MA et al. . Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol. 2012;11(3):217–224.
    1. Moore SA, Brown RD Jr, Christianson TJ, Flemming KD. Long-term natural history of incidentally discovered cavernous malformations in a single-center cohort. J Neurosurg. 2014;120(5):1188–1192.
    1. Flemming KD, Bovis GK, Meyer FB. Aggressive course of multiple de novo cavernous malformations. J Neurosurg. 2011;115(6):1175–1178.
    1. Gastelum E, Sear K, Hills N et al. . Rates and characteristics of radiographically detected intracerebral cavernous malformations after cranial radiation therapy in pediatric cancer patients. J Child Neurol. 2015;30(7):842–849.
    1. Flemming KD, Link MJ, Christianson TJ, Brown RD Jr.. Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology. 2012;78(9):632–636.
    1. Rigamonti D, Hadley MN, Drayer BP et al. . Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med. 1988;319(6):343–347.
    1. Zabramski JM, Wascher TM, Spetzler RF et al. . The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg. 1994;80(3):422–432.
    1. Gunel M, Awad IA, Finberg K et al. . A founder mutation as a cause of cerebral cavernous malformation in Hispanic Americans. N Engl J Med. 1996;334(15):946–951.
    1. Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Angioma Alliance Scientific Advisory Board. Stroke. 2008;39(12):3222–3230.
    1. Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg. 1991;75(5):709–714.
    1. Kondziolka D, Monaco EA 3rd, Lunsford LD. Cavernous malformations and hemorrhage risk. Prog Neurol Surg. 2013;27:141–146.
    1. Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg. 1997;87(2):190–197.
    1. Moriarity JL, Wetzel M, Clatterbuck RE et al. . The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery. 1999;44(6):1166–1171; discussion 1172-1163.
    1. Ghannane H, Khalil T, Sakka L, Chazal J. Analysis of a series of cavernomas of the central nervous system: 39 non operated cases, 39 operated cases, 1 dead. Neurochirurgie. 2007;53(2-3 pt 2):217–222.
    1. Kalani MY, Zabramski JM. Risk for symptomatic hemorrhage of cerebral cavernous malformations during pregnancy. J Neurosurg. 2013;118(1):50–55.
    1. Li D, Hao SY, Jia GJ, Wu Z, Zhang LW, Zhang JT. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations. J Neurosurg. 2014;121(1):32–41.
    1. Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg. 1995;83(1):56–59.
    1. Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg. 1995;83(5):820–824.
    1. Labauge P, Brunereau L, Laberge S, Houtteville JP. Prospective follow-up of 33 asymptomatic patients with familial cerebral cavernous malformations. Neurology. 2001;57(10):1825–1828.
    1. Mathiesen T, Edner G, Kihlstrom L. Deep and brainstem cavernomas: a consecutive 8-year series. J Neurosurg. 2003;99(1):31–37.
    1. Kim DS, Park YG, Choi JU, Chung SS, Lee KC. An analysis of the natural history of cavernous malformations. Surg Neurol. 1997;48(1):9–17; discussion 17-18.
    1. Barker FG 2nd, Amin-Hanjani S, Butler WE et al. . Temporal clustering of hemorrhages from untreated cavernous malformations of the central nervous system. Neurosurgery. 2001;49(1):15–24; discussion 24-25.
    1. Fritschi JA, Reulen HJ, Spetzler RF, Zabramski JM. Cavernous malformations of the brain stem. A review of 139 cases. Acta Neurochir. 1994;130(1-4):35–46.
    1. Porter RW, Detwiler PW, Spetzler RF et al. . Cavernous malformations of the brainstem: experience with 100 patients. J Neurosurg. 1999;90(1):50–58.
    1. Hasegawa T, McInerney J, Kondziolka D, Lee JY, Flickinger JC, Lunsford LD. Long-term results after stereotactic radiosurgery for patients with cavernous malformations. Neurosurgery. 2002;50(6):1190–1197; discussion 1197-1198.
    1. Wang CC, Liu A, Zhang JT, Sun B, Zhao YL. Surgical management of brain-stem cavernous malformations: report of 137 cases. Surg Neurol. 2003;59(6):444–454; discussion 454.
    1. Gross BA, Lin N, Du R, Day AL. The natural history of intracranial cavernous malformations. Neurosurg Focus. 2011;30(6):E24.
    1. Horne MA, Flemming KD, Su IC et al. . Clinical course of untreated cerebral cavernous malformations: a meta-analysis of individual patient data. Lancet Neurol. 2016;15(2):166–173.
    1. Cohen-Gadol AA, Jacob JT, Edwards DA, Krauss WE. Coexistence of intracranial and spinal cavernous malformations: a study of prevalence and natural history. J Neurosurg. 2006;104(3):376–381.
    1. Badhiwala JH, Farrokhyar F, Alhazzani W et al. . Surgical outcomes and natural history of intramedullary spinal cord cavernous malformations: a single-center series and meta-analysis of individual patient data. J Neurosurg Spine. 2014;21(4):662–676.
    1. Shenkar R, Shi C, Rebeiz T et al. . Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations. Genet Med. 2015;17(3):188–196.
    1. Washington CW, McCoy KE, Zipfel GJ. Update on the natural history of cavernous malformations and factors predicting aggressive clinical presentation. Neurosurg Focus. 2010;29(3):E7.
    1. Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology. 2011;76(18):1548–1554.
    1. van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J. Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988;19(5):604–607.
    1. Moultrie F, Horne MA, Josephson CB et al. . Outcome after surgical or conservative management of cerebral cavernous malformations. Neurology. 2014;83(7):582–589.
    1. Cordonnier C, Al-Shahi Salman R, Bhattacharya JJ et al. . Differences between intracranial vascular malformation types in the characteristics of their presenting haemorrhages: prospective, population-based study. J Neurol Neurosurg Psychiatry. 2008;79(1):47–51.
    1. Cavalcanti DD, Kalani MY, Martirosyan NL, Eales J, Spetzler RF, Preul MC. Cerebral cavernous malformations: from genes to proteins to disease. J Neurosurg. 2012;116(1):122–132.
    1. Riant F, Bergametti F, Ayrignac X, Boulday G, Tournier-Lasserve E. Recent insights into cerebral cavernous malformations: the molecular genetics of CCM. FEBS J. 2010;277(5):1070–1075.
    1. Fischer A, Zalvide J, Faurobert E, Albiges-Rizo C, Tournier-Lasserve E. Cerebral cavernous malformations: from CCM genes to endothelial cell homeostasis. Trends Mol Med. 2013;19(5):302–308.
    1. Yadla S, Jabbour PM, Shenkar R, Shi C, Campbell PG, Awad IA. Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution. Neurosurg Focus. 2010;29(3):E4.
    1. McDonald DA, Shi C, Shenkar R et al. . Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis. Hum Mol Genet. 2014;23(16):4357–4370.
    1. Akers AL, Johnson E, Steinberg GK, Zabramski JM, Marchuk DA. Biallelic somatic and germline mutations in cerebral cavernous malformations (CCMs): evidence for a two-hit mechanism of CCM pathogenesis. Hum Mol Genet. 2009;18(5):919–930.
    1. Haasdijk RA, Cheng C, Maat-Kievit AJ, Duckers HJ. Cerebral cavernous malformations: from molecular pathogenesis to genetic counselling and clinical management. Eur J Hum Genet. 2012;20(2):134–140.
    1. Petersen TA, Morrison LA, Schrader RM, Hart BL. Familial versus sporadic cavernous malformations: differences in developmental venous anomaly association and lesion phenotype. AJNR Am J Neuroradiol. 2010;31(2):377–382.
    1. de Champfleur NM, Langlois C, Ankenbrandt WJ et al. . Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging. Neurosurgery. 2011;68(3):641–647; discussion 647-648.
    1. Riant F, Cecillon M, Saugier-Veber P, Tournier-Lasserve E. CCM molecular screening in a diagnosis context: novel unclassified variants leading to abnormal splicing and importance of large deletions. Neurogenetics. 2013;14(2):133–141.
    1. Spiegler S, Najm J, Liu J et al. . High mutation detection rates in cerebral cavernous malformation upon stringent inclusion criteria: one-third of probands are minors. Mol Genet Genomic Med. 2014;2(2):176–185.
    1. Denier C, Labauge P, Brunereau L et al. . Clinical features of cerebral cavernous malformations patients with KRIT1 mutations. Ann Neurol. 2004;55(2):213–220.
    1. Cigoli MS, Avemaria F, De Benedetti S et al. . PDCD10 gene mutations in multiple cerebral cavernous malformations. PLoS One. 2014;9(10):e110438.
    1. D’Angelo R, Marini V, Rinaldi C et al. . Mutation analysis of CCM1, CCM2 and CCM3 genes in a cohort of Italian patients with cerebral cavernous malformation. Brain Pathol. 2011;21(2):215–224.
    1. Gault J, Sain S, Hu LJ, Awad IA. Spectrum of genotype and clinical manifestations in cerebral cavernous malformations. Neurosurgery. 2006;59(6):1278–1284; discussion 1284-1275.
    1. Mondejar R, Solano F, Rubio R et al. . Mutation prevalence of cerebral cavernous malformation genes in Spanish patients. PLoS One. 2014;9(1):e86286.
    1. Cave-Riant F, Denier C, Labauge P et al. . Spectrum and expression analysis of KRIT1 mutations in 121 consecutive and unrelated patients with cerebral cavernous malformations. Eur J Hum Genet. 2002;10(11):733–740.
    1. Liu XW, Wang SH, Chi ZF, Su LJ, Zhao XH, Wang SJ. The value of T(2) (*)-weighted gradient echo imaging for detection of familial cerebral cavernous malformation: A study of two families. Exp Ther Med. 2013;5(2):448–452.
    1. Golden M, Saeidi S, Liem B, Marchand E, Morrison L, Hart B. Sensitivity of patients with familial cerebral cavernous malformations to therapeutic radiation. J Med Imaging Radiat Oncol. 2015;59(1):134–136.
    1. Rigamonti D, Drayer BP, Johnson PC, Hadley MN, Zabramski J, Spetzler RF. The MRI appearance of cavernous malformations (angiomas). J Neurosurg. 1987;67(4):518–524.
    1. Campbell PG, Jabbour P, Yadla S, Awad IA. Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review. Neurosurg Focus. 2010;29(3):E6.
    1. Rigamonti D, Johnson PC, Spetzler RF, Hadley MN, Drayer BP. Cavernous malformations and capillary telangiectasia: a spectrum within a single pathological entity. Neurosurgery. 1991;28(1):60–64.
    1. Sze G, Krol G, Olsen WL et al. . Hemorrhagic neoplasms: MR mimics of occult vascular malformations. AJR Am J Roentgenol. 1987;149(6):1223–1230.
    1. Lehnhardt FG, von Smekal U, Ruckriem B et al. . Value of gradient-echo magnetic resonance imaging in the diagnosis of familial cerebral cavernous malformation. Arch Neurol. 2005;62(4):653–658.
    1. Dillon WP. Cryptic vascular malformations: controversies in terminology, diagnosis, pathophysiology, and treatment. AJNR Am J Neuroradiol. 1997;18(10):1839–1846.
    1. Wilms G, Marchal G, Van Hecke P, Van Fraeyenhoven L, Decrop E, Baert AL. Cerebral venous angiomas. MR imaging at 1.5 tesla. Neuroradiology. 1990;32(2):81–85.
    1. de Souza JM, Domingues RC, Cruz LC Jr, Domingues FS, Iasbeck T, Gasparetto EL. Susceptibility-weighted imaging for the evaluation of patients with familial cerebral cavernous malformations: a comparison with t2-weighted fast spin-echo and gradient-echo sequences. AJNR Am J Neuroradiol. 2008;29(1):154–158.
    1. Meng G, Bai C, Yu T et al. . The association between cerebral developmental venous anomaly and concomitant cavernous malformation: an observational study using magnetic resonance imaging. BMC Neurol. 2014;14:50.
    1. McDonald RJ, McDonald JS, Kallmes DF et al. . Intracranial gadolinium deposition after contrast-enhanced MR imaging. Radiology. 2015;275(3):772–782.
    1. Kanda T, Ishii K, Kawaguchi H, Kitajima K, Takenaka D. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium-based contrast material. Radiology. 2014;270(3):834–841.
    1. Cenzato M, Stefini R, Ambrosi C, Giovanelli M. Post-operative remnants of brainstem cavernomas: incidence, risk factors and management. Acta Neurochir. 2008;150(9):879–886; discussion 887.
    1. Tan H, Liu T, Wu Y et al. . Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping. Invest Radiol. 2014;49(7):498–504.
    1. Hart BL, Taheri S, Rosenberg GA, Morrison LA. Dynamic contrast-enhanced MRI evaluation of cerebral cavernous malformations. Transl Stroke Res. 2013;4(5):500–506.
    1. Mikati AG, Tan H, Shenkar R et al. . Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations. Stroke. 2014;45(2):598–601.
    1. Mikati AG, Khanna O, Zhang L et al. . Vascular permeability in cerebral cavernous malformations. J Cereb Blood Flow Metab. 2015;35(10):1632–1639.
    1. Hamilton BE, Nesbit GM, Dosa E et al. . Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging. AJR Am J Roentgenol. 2011;197(4):981–988.
    1. Poorthuis M, Samarasekera N, Kontoh K et al. . Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review. Acta Neurochir (Wien). 2013;155(4):643–649.
    1. Dalyai RT, Ghobrial G, Awad I et al. . Management of incidental cavernous malformations: a review. Neurosurg Focus. 2011;31(6):E5.
    1. Bilginer B, Narin F, Hanalioglu S, Oguz KK, Soylemezoglu F, Akalan N. Cavernous malformations of the central nervous system (CNS) in children: clinico-radiological features and management outcomes of 36 cases. Childs Nerv Syst. 2014;30(8):1355–1366.
    1. Pasqualin A, Meneghelli P, Giammarusti A, Turazzi S. Results of surgery for cavernomas in critical supratentorial areas. Acta Neurochir Suppl. 2014;119:117–123.
    1. Kivelev J, Koskela E, Setala K, Niemela M, Hernesniemi J. Long-term visual outcome after microsurgical removal of occipital lobe cavernomas. J Neurosurg. 2012;117(2):295–301.
    1. Liu JK, Lu Y, Raslan AM, Gultekin SH, Delashaw JB Jr.. Cavernous malformations of the optic pathway and hypothalamus: analysis of 65 cases in the literature. Neurosurg Focus. 2010;29(3):E17.
    1. Carrasco R, Pedrosa M, Pascual JM, Navas M, Liberal R, Sola RG. Cavernous angiomas of the lateral ventricles. Acta Neurochir. 2009;151(2):149–154.
    1. Gross BA, Batjer HH, Awad IA, Bendok BR. Cavernous malformations of the basal ganglia and thalamus. Neurosurgery. 2009;65(1):7–18; discussion 18-19.
    1. Li D, Zhang J, Hao S et al. . Surgical treatment and long-term outcomes of thalamic cavernous malformations. World Neurosurg. 2013;79(5-6):704–713.
    1. Gross BA, Batjer HH, Awad IA, Bendok BR, Du R. Brainstem cavernous malformations: 1390 surgical cases from the literature. World Neurosurg. 2013;80(1-2):89–93.
    1. Flores BC, Whittemore AR, Samson DS, Barnett SL. The utility of preoperative diffusion tensor imaging in the surgical management of brainstem cavernous malformations. J Neurosurg. 2015;122(3):653–662.
    1. Winkler D, Lindner D, Strauss G, Richter A, Schober R, Meixensberger J. Surgery of cavernous malformations with and without navigational support–a comparative study. Minim Invasive Neurosurg. 2006;49(1):15–19.
    1. Zhou H, Miller D, Schulte DM et al. . Transsulcal approach supported by navigation-guided neurophysiological monitoring for resection of paracentral cavernomas. Clin Neurol Neurosurg. 2009;111(1):69–78.
    1. Choudhri O, Karamchandani J, Gooderham P, Steinberg GK. Flexible omnidirectional carbon dioxide laser as an effective tool for resection of brainstem, supratentorial, and intramedullary cavernous malformations. Neurosurgery. 2014;10(suppl 1):34–34; discussion 43-35.
    1. Steinberg GK, Marks MP, Shuer LM, Sogg RL, Enzmann DR, Silverberg GD. Occult vascular malformations of the optic chiasm: magnetic resonance imaging diagnosis and surgical laser resection. Neurosurgery. 1990;27(3):466–470.
    1. Kharkar S, Shuck J, Conway J, Rigamonti D. The natural history of conservatively managed symptomatic intramedullary spinal cord cavernomas. Neurosurgery. 2007;60(5):865–872; discussion 865-872.
    1. Brelie C, von Lehe M, Raabe A et al. . Surgical resection can be successful in a large fraction of patients with drug-resistant epilepsy associated with multiple cerebral cavernous malformations. Neurosurgery. 2014;74(2):147–153; discussion 153.
    1. Rosenow F, Alonso-Vanegas MA, Baumgartner C et al. . Cavernoma-related epilepsy: review and recommendations for management–report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2013;54(12):2025–2035.
    1. Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci. 2006;26(6):390–394.
    1. Cohen DS, Zubay GP, Goodman RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg. 1995;83(2):237–242.
    1. von der Brelie C, Kuczaty S, von Lehe M. Surgical management and long-term outcome of pediatric patients with different subtypes of epilepsy associated with cerebral cavernous malformations. J Neurosurg Pediatr. 2014;13(6):699–705.
    1. McCracken DJ, Willie JT, Fernald BA et al. . Magnetic resonance thermometry-guided stereotactic laser ablation of cavernous malformations in drug-resistant epilepsy: imaging and clinical results. Oper Neurosurg. 2016;12(1):39–48.
    1. Zhang P, Liu L, Cao Y, Wang S, Zhao J. Cerebellar cavernous malformations with and without associated developmental venous anomalies. BMC Neurol. 2013;13:134.
    1. Lee SH, Choi HJ, Shin HS, Choi SK, Oh IH, Lim YJ. Gamma knife radiosurgery for brainstem cavernous malformations: should a patient wait for the rebleed? Acta Neurochir. 2014;156(10):1937–1946.
    1. Sager O, Beyzadeoglu M, Dincoglan F et al. . Evaluation of linear accelerator (LINAC)-based stereotactic radiosurgery (SRS) for cerebral cavernous malformations: a 15-year single-center experience. Ann Saudi Med. 2014;34(1):54–58.
    1. Lu XY, Sun H, Xu JG, Li QY. Stereotactic radiosurgery of brainstem cavernous malformations: a systematic review and meta-analysis. J Neurosurg. 2014;120(4):982–987.
    1. Lunsford LD, Khan AA, Niranjan A, Kano H, Flickinger JC, Kondziolka D. Stereotactic radiosurgery for symptomatic solitary cerebral cavernous malformations considered high risk for resection. J Neurosurg. 2010;113(1):23–29.
    1. Niranjan A, Lunsford LD. Stereotactic radiosurgery guidelines for the management of patients with intracranial cavernous malformations. Prog Neurol Surg. 2013;27:166–175.
    1. Kondziolka D, Lunsford LD, Coffey RJ, Bissonette DJ, Flickinger JC. Stereotactic radiosurgery of angiographically occult vascular malformations: indications and preliminary experience. Neurosurgery. 1990;27(6):892–900.
    1. Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus. 2006;21(1):e7.
    1. Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery. 2008;63(5):888–896; discussion 897.
    1. Batra S, Lin D, Recinos PF, Zhang J, Rigamonti D. Cavernous malformations: natural history, diagnosis and treatment. Nat Rev Neurol. 2009;5(12):659–670.
    1. Leigh R, Wityk RJ. Special problems in cavernous malformations: migraine, pregnancy, hormonal replacement, anticoagulation, NSAIDs. In: Rigamonti D. Cavernous Malformations of the Central Nervous System. Cambridge: Cambridge University Press; 2011:185–191.
    1. Li H, Ju Y, Cai BW, Chen J, You C, Hui XH. Experience of microsurgical treatment of brainstem cavernomas: report of 37 cases. Neurol India. 2009;57(3):269–273.
    1. Li D, Hao SY, Tang J et al. . Surgical management of pediatric brainstem cavernous malformations. J Neurosurg Pediatr. 2014;13(5):484–502.
    1. Choi H, Kim CH, Lee KY, Lee YJ, Koh SH. A probable cavernoma in the medulla oblongata presenting only as upbeat nystagmus. J Clin Neurosci. 2011;18(11):1567–1569.
    1. Gross BA, Smith ER, Scott RM. Cavernous malformations of the basal ganglia in children. J Neurosurg Pediatr. 2013;12(2):171–174.
    1. Li D, Hao SY, Tang J et al. . Clinical course of untreated pediatric brainstem cavernous malformations: hemorrhage risk and functional recovery. J Neurosurg Pediatr. 2014;13(5):471–483.
    1. Nikoubashman O, Wiesmann M, Tournier-Lasserve E et al. . Natural history of cerebral dot-like cavernomas. Clini Radiol. 2013;68(8):e453–e459.
    1. Gross BA, Du R, Orbach DB, Scott RM, Smith ER. The natural history of cerebral cavernous malformations in children. J Neurosurg Pediatr. 2015:1–6[Epub ahead of print].
    1. Consales A, Piatelli G, Ravegnani M et al. . Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients. Neurol Sci. 2010;31(2):117–123.
    1. Bigi S, Capone Mori A, Steinlin M, Remonda L, Landolt H, Boltshauser E. Cavernous malformations of the central nervous system in children: presentation, treatment and outcome of 20 cases. Eur J Paediatr Neurol. 2011;15(2):109–116.
    1. Faraci M, Morana G, Bagnasco F et al. . Magnetic resonance imaging in childhood leukemia survivors treated with cranial radiotherapy: a cross sectional, single center study. Pediatr Blood Cancer. 2011;57(2):240–246.
    1. Heckl S, Aschoff A, Kunze S. Radiation-induced cavernous hemangiomas of the brain: a late effect predominantly in children. Cancer. 2002;94(12):3285–3291.
    1. Witiw CD, Abou-Hamden A, Kulkarni AV, Silvaggio JA, Schneider C, Wallace MC. Cerebral cavernous malformations and pregnancy: hemorrhage risk and influence on obstetrical management. Neurosurgery. 2012;71(3):626–630; discussion 631.
    1. Yamada S, Nakase H, Nakagawa I, Nishimura F, Motoyama Y, Park YS. Cavernous malformations in pregnancy. Neurol Med Chir (Tokyo). 2013;53(8):555–560.
    1. Flemming KD, Link MJ, Christianson TJ, Brown RD Jr.. Use of antithrombotic agents in patients with intracerebral cavernous malformations. J Neurosurg. 2013;118(1):43–46.
    1. Schneble HM, Soumare A, Herve D et al. . Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke. 2012;43(12):3196–3199.
    1. Erdur H, Scheitz JF, Tutuncu S et al. . Safety of thrombolysis in patients with acute ischemic stroke and cerebral cavernous malformations. Stroke. 2014;45(6):1846–1848.
    1. Kumar S, Puri V, Malik R, Gupta S. Cerebral cavernous angioma. Indian Pediatr. 1991;28(6):675–678.
    1. Berg MJ, Vay T. Clinical features and medical management of cavernous malformations. In: Rigamonti D, ed. Cavernous Malformations of the Nervous System. Vol. 2011 Cambridge, England: Cambridge University Press; 2011:65–78.
    1. Girard R, Khanna O, Shenkar R et al. . Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease. Biomark Med. 2016;10(3):255–264.
    1. Neurosurgery. 2013March;72Suppl 2:1 doi: 10.1227/NEU.0b013e318276ee7e. Updated Guidelines for the Management of Acute Cervical Spine and Spinal Cord Injury. Resnick DK1.
    1. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition Carney N, Totten AM, OReilly C, Ullman JS, Hawryluk GW, Bell MJ, Bratton SL, Chesnut R, Harris OA, Kissoon N, Rubiano AM, Shutter L, Tasker RC, Vavilala MS, Wilberger J, Wright DW, Ghajar J. Neurosurgery. 2016September20.
    1. Zabrmaski J., Kalani M. Y. Natural History of Cerebral Cavernous Malformations. Youmans and Winn Neurological Surgery, 4-Volume Set, 7th Edition, 2016.
    1. Propranolol Treatment of Cavernous Malformations with Symptomatic Hemorrhage. Zabramski JM, Kalani MY, Filippidis AS, Spetzler RF. World Neurosurg. 2016April;88:631–9.
    1. McDonald D.A., Shi C., Shenkar R., Stockton R.A., Liu F., Ginsberg M.H. et al. . Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke, 43 (2012), pp. 571–574.
    1. Shenkar R, Shi C, Austin C et al. . RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations. Stroke. 2017; 48(1):187–194.

Source: PubMed

Sponsor e collaboratori

Condizioni mediche

Interventi farmacologici

3
Sottoscrivi